Strungmann twins, partners with Uğur Şahin and Özlem Türeci, have become among the richest in the country.
BioNTech, whose shares have increased by 250 percent in the last six months with the vaccine they developed against COVID 19, made Uğur Şahin rich. The Strungmann twins, who invested in the company years ago, received the lion’s share of the profits.
The twins have climbed to the top of the list of the wealthiest people in Germany.
The Strungmann twins, who contributed financially to BioNTech, which was founded by Uğur Şahin and Özlem Türeci years ago, were on the agenda of Germany.
BioNTech’s Ugur Sahin and Ozlem Tureci
The biggest winners from this situation are Uğur Şahin, the founder of BioNTech, along with the Strungmann twins Thomas and Andreas. Şahin bought approximately 17 percent of the Mainz-based company, which corresponds to approximately 12 billion euros.
According to this data, Şahin, the son of a Turkish worker, is among the richest Germans.
